Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2

Outbreak of Coronavirus Disease 2019 (COVID-19) has become a great challenge for scientific community globally. Virus enters cell through spike glycoprotein fusion with ACE2 (Angiotensin-Converting Enzyme 2) human receptor. Hence, spike glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :In Silico Pharmacol
Главные авторы: Rathod, Shravan B., Prajapati, Pravin B., Punjabi, Lata B., Prajapati, Kuntal N., Chauhan, Neha, Mansuri, Mohmedyasin F.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Berlin Heidelberg 2020
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7649901/
https://ncbi.nlm.nih.gov/pubmed/33184600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40203-020-00055-w
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы